Skip to main content
Caplight Logo









NIH Helping to End Addiction Long-term (HEAL) Initiative

NIH Helping to End Addiction Long-term (HEAL) Initiative

Bethesda, Marylandnih.gov

Overview

The NIH Helping to End Addiction Long-term (HEAL) Initiative is a trans-NIH effort launched in 2018 to accelerate scientific solutions to the national opioid public health crisis by improving treatments for opioid misuse and addiction and enhancing pain management.

Year Founded

2018

Portfolio Companies

7

Website

nih.gov

Investments

NIH Helping to End Addiction Long-term (HEAL) Initiative investments
CompanyDateStageLead
Quiver BioscienceMay 2026GrantCo-investor
Lutroo ImagingJul 2023GrantCo-investor
EicOsis Human Health, Inc.Oct 2019GrantCo-investor
1910 GeneticsSep 2021GrantCo-investor
Book a demo to see all 7 portfolio companies

For institutional investors. Book with your work email.

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Portfolio analytics

Caplight clients see full sector, stage and valuation breakdowns for this investor.

Book a demo to see full analytics

For institutional investors. Book with your work email.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Portfolio analytics

Caplight clients see yearly investment pace and funding raised over time.

Book a demo to see full analytics

For institutional investors. Book with your work email.

FAQ

Where is NIH Helping to End Addiction Long-term (HEAL) Initiative based?

NIH Helping to End Addiction Long-term (HEAL) Initiative is headquartered in Bethesda, Maryland, United States.

When was NIH Helping to End Addiction Long-term (HEAL) Initiative founded?

NIH Helping to End Addiction Long-term (HEAL) Initiative was founded in 2018.

How many portfolio companies does NIH Helping to End Addiction Long-term (HEAL) Initiative have?

NIH Helping to End Addiction Long-term (HEAL) Initiative has 7 portfolio companies in Caplight's dataset.

What are some companies in NIH Helping to End Addiction Long-term (HEAL) Initiative's portfolio?

Portfolio companies visible on Caplight include Quiver Bioscience, Lutroo Imaging, EicOsis Human Health, Inc., 1910 Genetics.

What was NIH Helping to End Addiction Long-term (HEAL) Initiative's most recent investment shown here?

NIH Helping to End Addiction Long-term (HEAL) Initiative's most recent investment in this portfolio sample was in Quiver Bioscience in 2026.

What sectors does NIH Helping to End Addiction Long-term (HEAL) Initiative focus on?

NIH Helping to End Addiction Long-term (HEAL) Initiative focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, AI, Data & Cloud Infrastructure, Frontier & Industrial Tech, AI, Data & Cloud Infrastructure.

What company stages does NIH Helping to End Addiction Long-term (HEAL) Initiative focus on?

Stage focus information for NIH Helping to End Addiction Long-term (HEAL) Initiative is not publicly available.

What is NIH Helping to End Addiction Long-term (HEAL) Initiative's AUM?

NIH Helping to End Addiction Long-term (HEAL) Initiative's assets under management are estimated at over $3.2B.

Firmographic Details

HeadquartersBethesda, Maryland
Year Founded2018

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?